PaparaCDe LucaDABieberKVorobyevALudwigRJ. Morphea: the 2023 update. Front Med. 2023;10:1108623. doi:10.3389/fmed.2023.1108623
2.
SteinTCieplewicz-GuźlaPIżykowskaK, et al. What is new in morphea—narrative review on molecular aspects and new targeted therapies. J Clin Med. 2024;13(23):7134. doi:10.3390/jcm13237134
3.
FertinCNicolasJFGilleryPKalisBBanchereauJMaquartFX. Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents. Cell Mol Biol. 1991;37(8):823-829.
4.
Malewska-WoźniakAOsmola-MañkowskaAAdamskiZ. Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients. Adv Dermatol Allergol. 2022;39(4):757-761. doi:10.5114/ada.2021.108437
5.
CampioneEPaternòEJDiluvioLOrlandiABianchiLChimentiS. Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness. J Dermatol Treat. 2009;20(1):10-13. doi:10.1080/09546630802132668
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
